Evidence map›Paper›PMID 31485205›Full record

ReviewPrzeglad menopauzalny = Menopause review2019

A comparison of sacral neuromodulation vs. transvaginal electrical stimulation for the treatment of refractory overactive bladder: the impact on quality of life, body image, sexual function, and emotional well-being.

Valentina Lucia La Rosa, Alessio Platania, Michał Ciebiera, Simone Garzon, Robert Jędra, Marco Ponta, Salvatore Butticè

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Przeglad menopauzalny = Menopause review, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05668715 (Comparison of the Efficacy of Transcutaneous Tibial Nerve Stimulation in Antimuscarinic Naive and Refractory Women With Idiopathic Overactive Bladder), which is not on this map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05668715 naunknown statusnot on this mapstarted 2023, after this paper: background citation

Comparison of the Efficacy of Transcutaneous Tibial Nerve Stimulation in Antimuscarinic Naive and Refractory Women With Idiopathic Overactive Bladder

TypeinterventionalSponsorPamukkale UniversityRan2023 to 2023Enrolled40ConditionsUrinary Bladder, OveractiveArmsTranscutaneous tibial nerve stimulation (TTNS)
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. An update on treatment options for interstitial cystitis.Przeglad menopauzalny = Menopause review · 2020
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 2 countries.

Valentina Lucia La RosaUnit of Psychodiagnostics and Clinical Psychology, University of Catania, Catania, Italy.
Alessio PlataniaJames Street Family Practice, Louth, UK.
Michał CiebieraSecond Department of Obstetrics and Gynaecology, The Centre of Postgraduate Medical Education, Warsaw, Poland.
Simone GarzonDepartment of Obstetrics and Gynaecology, "Filippo Del Ponte" Hospital, University of Insubria, Varese, Italy.
Robert JędraSecond Department of Obstetrics and Gynaecology, The Centre of Postgraduate Medical Education, Warsaw, Poland.
Marco PontaDepartment of Neurosciences and Reproductive and Odontostomatological Sciences, University of Naples Federico II, Naples, Italy.
Salvatore ButticèDepartment of Urology, San Giovanni di Dio Hospital, Agrigento, Italy.
Postgraduate School of Molecular Medicine · PLNuovo Ospedale San Giovanni di Dio · ITOspedale Filippo Del Ponte Varese · ITUniversity of Catania · ITUniversity of Naples Federico II · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Overactive bladder syndrome (OAB) is defined by the presence of urinary urgency, with or without urge incontinence, usually accompanied by an increase in urinary frequency and nocturia in the absence of urinary tract infections (UTI) or other diseases. The overall prevalence of OAB symptoms in the female population is reported to be 16.6% and increases with advancing age and menopause. The aetiology of OAB is not fully understood and is likely to affect a heterogeneous population of patients due to changes to their central and peripheral nervous systems. Although OAB is frequently associated with female sexual dysfunction (FSD), its real impact on sexual function in women has been evaluated only in a few studies. The first line of treatment for OAB includes behavioural modification and physical therapy, either as monotherapies or in combination. Many patients who have not had success in managing their symptoms with more conservative therapies may decide to resort to third-line treatments for refractory OAB. These treatments include neuromodulation therapies, particularly transvaginal electrical stimulation (TES) and sacral neuromodulation (SN). The aim of this short commentary is to provide an overview of the effectiveness of these treatments and of their impact on quality of life, body image, sexual function, and emotional well-being.

Indexed as

menopauseoveractive bladder syndromequality of lifesacral neuromodulationsexual functiontransvaginal electrical stimulation

Identifiers

PMID31485205
PMCPMC6719634
OpenAlexW2969490116

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.